News Summary:
- waters_connect™ Data Intelligence software provides
laboratories with comprehensive business intelligence on their
chromatographic data throughout the product development lifecycle,
enabling real-time audit readiness and query response, while
reducing time spent on audit preparation.
- Cloud-based software proactively provides visibility into risks
that could trigger adverse regulatory findings, delivering seamless
remote data access, comprehensive analytics, historical trends,
scalability, and cost efficiency.
- Provides actionable insights from Waters™ Empower™ CDS software
to help prevent system suitability failures, that can cost up to
$600,000 per year.i
MILFORD,
Mass., Nov. 7, 2024 /PRNewswire/ -- Waters
Corporation (NYSE: WAT) today announced waters_connect Data
Intelligence software, a new cloud-based application that helps
customers in regulated industries improve how they access,
organize, analyze, and drive productivity from laboratory
information. The software leverages data from Waters Empower
Chromatography Data System (CDS) enabling laboratories to achieve
confident audit-readiness, helping laboratory managers respond more
quickly to audit inquiries with insights, and making informed
decisions faster.
waters_connect Data Intelligence software
provides laboratories with comprehensive business intelligence on
chromatographic data.
"Organizations need to ensure there are no missteps with data
quality and integrity to avoid product release delays and failed
quality regulatory audits that can cost tens of millions of dollars
and delay lifesaving treatments," said Dave
Leitham, Vice President, Connected Science at Waters
Corporation. "waters_connect Data Intelligence software provides
organizations with a new level of transparency into their data,
making it easier to analyze and deliver valuable operational and
scientific insights in real time, thus enhancing readiness for
business-critical audits."
Designed to work with Empower CDS, waters_connect Data
Intelligence software generates in-depth, configurable dashboards
that deliver advanced analytical insights on laboratory data such
as aborted injections and sample sets to help reduce the risks
associated with adverse findings in regulatory audits. Where users
of Empower CDS can take, on average, two days to respond to an
auditor's question,ii they can instead avoid costly
manual data consolidation and interpretation that could lead to
data analysis errors.
waters_connect Data Intelligence software is designed to work
seamlessly with Empower today and in the future, eliminating costly
integrations to homegrown or external applications. It provides
real-time remote data access, seamless tracking of long-term trends
and patterns, and always reflects the latest data from any
Empower-connected instrument. The software enables trending of
method, column, and instrument suitability data, which helps
preempt failures before they happen. The annual cost of system
suitability failures in pharma laboratories is estimated to be
$600,000 based on two failures per
month.
"From the early demos and usage of the new software, we really
like the flexibility that the waters_connect Data Intelligence tool
offers for tracking system usage, column shelf-life, and user
utilization," said Donny Preiss,
Associate Director, IT Lab Applications at biopharmaceutical
company, MannKind Corporation. "The new software will allow for
streamlined processes in our laboratory, more meaningful data
usage, and quicker business decisions."
waters_connect Data Intelligence software can be tailored to
organizations with single or multiple Empower CDS instances and is
available for demonstration and quoting now, and to order in
December 2024.
Additional Resources
- Learn more at waters_connect Data Intelligence
- Link to the product brochure and infographic
- Follow and connect with Waters via LinkedIn, Twitter, and
Facebook
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), a global leader in
analytical instruments and software, has pioneered chromatography,
mass spectrometry, and thermal analysis innovations serving the
life, materials, food, and environmental sciences for more than 65
years. With approximately 7,500 employees worldwide, Waters
operates directly in 35 countries, including 14 manufacturing
facilities, and with products available in more than 100
countries.
Waters, waters_connect, and Empower are trademarks of
Waters Technologies Corporation.
Contact:
Janice Foley
Senior Public Relations Manager, Corporate Communications
Waters Corporation
janice_foley@waters.com
+1.617.823.5555
|
____________________________
|
|
i Based on an average cost
of $25,000 per failure, including a batch release delay of 48 hours
for a typical small molecule drug, according to data acquired from
a cohort of 19 customers during Waters User Executive studies. As
an illustrative example of two system suitability failures per
month, the average annual cost can be $600,000.
|
|
|
ii Based
on Waters internal analysis and estimates.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/waters-new-software-delivers-lab-centric-business-intelligence-and-enables-confident-audit-readiness-302298143.html
SOURCE Waters Corporation
